{'fraction_non_alphanumeric': 0.022187004754358162, 'fraction_numerical': 0.006339144215530904, 'mean_word_length': 5.383838383838384, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Kidney Injury Molecule‐1 is an Early Noninvasive Indicator for Donor Brain Death‐Induced Injury Prior to Kidney Transplantation

With more marginal deceased donors affecting graft viability, there is a need for specific parameters to assess kidney graft quality at the time of organ procurement in the deceased donor. Recently, kidney injury molecule‐1 (Kim‐1) was described as an early biomarker of renal proximal tubular damage. We assessed Kim‐1 in a small animal brain death model as an early and noninvasive marker for donor‐derived injury related to brain death and its sequelae, with subsequent confirmation in human donors.